• Login
    Browsing by Subject 
    •   ORKA Home
    • Browsing by Subject
    •   ORKA Home
    • Browsing by Subject
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browsing by Subject "Pandemics"

    • 0-9
    • A
    • B
    • C
    • D
    • E
    • F
    • G
    • H
    • I
    • J
    • K
    • L
    • M
    • N
    • O
    • P
    • Q
    • R
    • S
    • T
    • U
    • V
    • W
    • X
    • Y
    • Z

    Sort by:

    Order:

    Results:

    Now showing items 1-4 of 4

    • title
    • issue date
    • submit date
    • xmlui.ArtifactBrowser.ConfigurableBrowse.sort_by.discipline
    • ascending
    • descending
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
      • Thumbnail

        Coronavirus conspiracy beliefs, mistrust, and compliance with government guidelines in England 

        Freeman, Daniel; Waite, Felicity; Rosebrock, Laina; Petit, Ariane; Causier, Chiara; East, Anna; Jenner, Lucy; Teale, Ashley-Louise; Carr, Lydia; Mulhall, Sophie; Bold, Emily; Lambe, Sinead (2020-05)
        Background: An invisible threat has visibly altered the world. Governments and key institutions have had to implement decisive responses to the danger posed by the coronavirus pandemic. Imposed change will increase the ...
      • Thumbnail

        Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses 

        External author(s) only (2020-12)
        More than 190 vaccines are currently in development to prevent infection by the novel severe acute respiratory syndrome coronavirus 2. Animal studies suggest that while neutralizing antibodies against the viral spike protein ...
      • Thumbnail

        Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial 

        External author(s) only (2020-12)
        Background Older adults (aged ≥70 years) are at increased risk of severe disease and death if they develop COVID-19 and are therefore a priority for immunisation should an efficacious vaccine be developed. Immunogenicity ...
      • Thumbnail

        Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial 

        External author(s) only (2020-07)
        Background The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) might be curtailed by vaccination. We assessed the safety, reactogenicity, and immunogenicity of a viral vectored coronavirus vaccine ...

        Oxford Health copyright © 2019
        Contact Us | Send Feedback | JSPUI
        Powered by KnowledgeArc
         

         

        Browse

        All of ORKACommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsContributor Discipline

        My Account

        Login

        Researcher Profiles

        Researchers

        Oxford Health copyright © 2019
        Contact Us | Send Feedback | JSPUI
        Powered by KnowledgeArc